U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Santos Agency Inc. - 521298 - 04/02/2018
  1. Warning Letters

CLOSEOUT LETTER

Santos Agency Inc. MARCS-CMS 521298 —

Recipient:
Santos Agency Inc.

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA Logo

 

 
 
Office of Human and Animal Foods Division West 5
San Francisco District Office
1431 Harbor Bay Parkway, Alameda, CA 94502
Telephone: 510-337-6700 

UNITED PARCEL SERVICE
SIGNATURE REQUIRED

April 02, 2018

Mr. Santos Parmar, Manager
Santo Agency Inc.
1188 Montague Street
San Leandro, CA 94577

Dear Mr. Santos Parmar:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 521298), dated April 03, 2017. Based on our evaluation, it appears that you have addressed the violation(s) contained in thisWarning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

Sergio Chavez,
Director of Compliancegiant

 

Back to Top